Skip to content

Retrospective Review of Xen Gel Stent Implantation With Open vs. Closed Conjunctiva Approach

Retrospective Review of Xen Gel Stent Implantation With Open vs. Closed Conjunctiva Approach

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04406467
Enrollment
137
Registered
2020-05-28
Start date
2017-11-19
Completion date
2020-08-26
Last updated
2023-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, Open-Angle

Keywords

Glaucoma surgery, Xen Gel Stent

Brief summary

To measure surgical success of open vs closed conjunctiva with Xen implantation.

Detailed description

This retrospective, single-arm multicenter study included \>100 eyes (\>100 patients) with glaucoma refractory to medical therapy. All surgeries were performed by two groups of surgeons at Johns Hopkins University and the sub-investigator group at New York University. Group 1: Xen with open conjunctiva for positioning and application of mitomycin. The Xen was placed through the sclera either ab-interno or ab-externa. Group 2 had Xen placed ab-interno or ab-externa (trans conjunctival), but the conjunctiva was not opened for positioning or application of mitomycin-C. Success rates will be determined based on need for re-intervention and intraocular pressure control.

Interventions

DEVICEXen Gel Stent

Ab-interno or Ab-Externa Xen with closed or open conjunctiva.

Sponsors

New York University
CollaboratorOTHER
Johns Hopkins University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Require surgery for uncontrolled glaucoma

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
re-intervention rate3 monthsThis will be assessed as the proportion of patients that will need fibrosis relief by stent re-implantation

Secondary

MeasureTime frameDescription
Change in intraocular pressure1 day, 1 week, 1 month and 3 monthswill be assessed as a % change in intraocular pressure

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026